KR20240000637A - 인지 기능을 개선시키기 위한 식물 추출물 - Google Patents

인지 기능을 개선시키기 위한 식물 추출물 Download PDF

Info

Publication number
KR20240000637A
KR20240000637A KR1020237043652A KR20237043652A KR20240000637A KR 20240000637 A KR20240000637 A KR 20240000637A KR 1020237043652 A KR1020237043652 A KR 1020237043652A KR 20237043652 A KR20237043652 A KR 20237043652A KR 20240000637 A KR20240000637 A KR 20240000637A
Authority
KR
South Korea
Prior art keywords
extract
plant
day
administered
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237043652A
Other languages
English (en)
Korean (ko)
Inventor
미첼 체디아
켈리 헤어링거
브랜던 루이스
크리스틴 니만
슈린 펭
Original Assignee
케민 인더스트리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 케민 인더스트리즈, 인코포레이티드 filed Critical 케민 인더스트리즈, 인코포레이티드
Publication of KR20240000637A publication Critical patent/KR20240000637A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020237043652A 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물 Pending KR20240000637A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462050563P 2014-09-15 2014-09-15
US62/050,563 2014-09-15
KR1020177010105A KR20170054501A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물
PCT/US2015/050230 WO2016044299A1 (en) 2014-09-15 2015-09-15 Plant extracts for improving cognitive function

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020177010105A Division KR20170054501A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Publications (1)

Publication Number Publication Date
KR20240000637A true KR20240000637A (ko) 2024-01-02

Family

ID=55453722

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020237043652A Pending KR20240000637A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물
KR1020177010105A Ceased KR20170054501A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020177010105A Ceased KR20170054501A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Country Status (8)

Country Link
US (2) US10857195B2 (https=)
EP (1) EP3194028A4 (https=)
JP (3) JP2017527591A (https=)
KR (2) KR20240000637A (https=)
AU (1) AU2015317990B2 (https=)
BR (1) BR112017005133A2 (https=)
CA (1) CA2961378A1 (https=)
WO (1) WO2016044299A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
CN116474049A (zh) * 2023-03-17 2023-07-25 深圳福图仁泰生物科技有限公司 一种兼具抗抑郁和促睡眠功效的植物天然水溶性复合物及其制备方法和应用
GB202402670D0 (en) * 2024-02-26 2024-04-10 Givaudan Sa Composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752476A (en) * 1986-02-18 1988-06-21 Copney Claudette V Sleep aiding herbal composition and method of utilizing same
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
JP2002275061A (ja) * 2001-03-19 2002-09-25 Tsumura & Co 抗うつ・抗不安剤
JP3947149B2 (ja) * 2002-10-28 2007-07-18 高砂香料工業株式会社 消臭剤組成物
CN1566300A (zh) * 2003-07-09 2005-01-19 新疆芳香植物科技开发股份有限公司 制造香囊、香枕的芳香组合物及其制备方法
JP2005053891A (ja) * 2003-07-18 2005-03-03 Seresu Corporation:Kk リパーゼ阻害剤
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
US20100137433A1 (en) * 2007-01-24 2010-06-03 Laima Kott Production of Rosmarinic Acid from Spearmint and uses Thereof
WO2008122099A1 (en) * 2007-04-05 2008-10-16 Iomedix Development International Srl Composition for promoting sleep and relaxation comprising lemon balm
ES2561330T3 (es) * 2007-10-17 2016-02-25 Rudolf Wild Gmbh & Co. Kg Composición que comprende extractos de toronjil
WO2009106121A1 (en) * 2008-02-25 2009-09-03 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway
JP2010106001A (ja) 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤
EP2398340A2 (en) * 2009-02-20 2011-12-28 DSM IP Assets B.V. Oregano extract for alertness
CN102958529B (zh) * 2009-12-21 2015-12-09 马来西亚热带生物有限公司 有益地用作认知增强剂的肾茶提取物
US9545076B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0042
US9545075B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0110
JP5668258B2 (ja) * 2011-10-21 2015-02-12 ザ マッキス カンパニー インコーポレイテッド エゴマの葉マッコリ及びその製造方法
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
US20140302170A1 (en) * 2013-04-08 2014-10-09 Scientific Nutrition Products, Inc. Compositions and methods for promoting sleep
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物

Also Published As

Publication number Publication date
US20160074459A1 (en) 2016-03-17
EP3194028A1 (en) 2017-07-26
JP2017527591A (ja) 2017-09-21
AU2015317990A1 (en) 2017-04-06
KR20170054501A (ko) 2017-05-17
JP7818640B2 (ja) 2026-02-20
WO2016044299A1 (en) 2016-03-24
JP2024075715A (ja) 2024-06-04
EP3194028A4 (en) 2018-10-10
BR112017005133A2 (en) 2018-01-23
JP2022084873A (ja) 2022-06-07
AU2015317990B2 (en) 2020-04-30
CA2961378A1 (en) 2016-03-24
US20160166629A1 (en) 2016-06-16
US10857195B2 (en) 2020-12-08

Similar Documents

Publication Publication Date Title
JP7818640B2 (ja) 睡眠を改善するための植物抽出物
JP7360267B2 (ja) 認知機能を向上させるための植物抽出物
Sarris et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence
JP2021525709A (ja) 自閉症スペクトラム障害の治療のためのカンナビスベースの組成物
Ghaffari et al. Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control
Manzoor et al. A Comprehensive Review on Anxiolytic Effect of Lavandula Angustifolia Mill. in Clinical Studies
JP2019520806A (ja) Ｌ−テアニン、プロアントシアニジン及びカテキンを含む組成物及びその使用
CA3056731A1 (en) Compositions comprising essential oils for topical use
Recart et al. Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase
Bongartz et al. Sleep Promoting Effects of IQP‐AO‐101: A Double‐Blind, Randomized, Placebo‐Controlled Exploratory Trial
Morgan et al. Outcomes of self-help efforts in anxiety disorders
Kim et al. Physiological and psychological effects of forest healing focused on plant fragrance therapy for maladjusted soldiers
Tarfarosh et al. Search for a perfect Nootropic supplement combination-Can we increase human intelligence by nutritional supplements
Ghaderi et al. The Effect Of Cinnamon Zeylanicum Essential Oil On Treatment Of Patients With Unipolar Nonpsychotic Major Depressive Disorder Treated With Fluoxetine
Sethi et al. Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions
Bongartz et al. Research Article Sleep Promoting Effects of IQP-AO-101: A Double-Blind, Randomized, Placebo-Controlled Exploratory Trial
Gündüz et al. Aromatherapeutic Remedies to Ease The Work Related Stress
Nair Role of Dietary Supplements on Mental Function
Diamond et al. COMPLEMENTARY, ALTERNATIVE, AND IN INTEGRATIVE THE TREATMENT MEDICINE AND MANAGEMENT OF DEMENTIA
Oken Non-prescription and non-pharmacological therapies for dementia
Kure Cognitive health
Johnson Natural Stress Relief
Braun Kava Kava: Piper Methysticum

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000